Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

On the Antithrombotic Effects of Doxazosin and Ramipril in Essential Hypertension

NCT02901977 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT02901977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02901977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
On the Antithrombotic Effects of Doxazosin and Ramipril in Essential Hypertension
Lead sponsor
Karolinska Institutet
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2011
Completion date
April 30, 2015
Enrollment
71 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension